Upstate Active Clinical Trials

Study Title:

An Open Label, Randomized, Adaptive, Two-Arm, Multicenter Trial to Evaluate Pharmackinetics and Pharmacodynamics of Two Doses of Oseltamivir (Tamilflu) in the Treatment of Influenza in Immunocompromised Children, Less than 13 Years of Age, with Confirmed Influenza Infection.

What is the purpose of the study? (in Layman's terms, please describe the study)

To investigate the safety and tolerability of twice daily conventional and double dose Tamiflu (oseltamivir) for the treatment of influenza in immunocompromised patients.

Upstate Institutional Review Board (IRB) Number:

397031

Study/Protocol ID:

NV27519

Study Phase:

1B

Patient Age Group:

Children

Principal Investigator:

Leonard B Weiner

What is involved if I participate?

• How long is the study?
  35-50 days total
• Is transportation provided or reimbursed?
  Yes
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Vital signs, blood work, nasal swabs.

ClinicalTrials.Gov ID:

NCT00545532

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Wendy A Holz
Phone: 315-464-7562
Email: [email protected]

Return to Previous Page || Search Again